Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that skin and nail changes can indicate various underlying health conditions.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The objective approach for creating search strategies is as effective as the traditional method and might be better and more efficient.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

The document concludes that cosmetics need biocompatible, eco-friendly ingredients due to aging populations and demand for effective products.

Antibody treatments show promise for hair loss but need more research.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

3D bioprinting improves wound healing by precisely creating scaffolds with living cells and biomaterials, but faces challenges like resolution and speed.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

New genetic mutations linked to rare skin disorders were found in three newborns.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

A Brazilian male with IFAP syndrome has a unique genetic variant causing his condition.

Biologics for severe asthma have known side effects, but some new risks need more study.

Testosterone's effects on COVID-19 are unclear and need more research.

Innovative methods are reducing animal testing and improving biomedical research.

The topical finasteride spray was safe and well-tolerated with stable effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

COVID-19 may worsen with androgens; anti-androgen drugs could help.